EMEA-003040-PIP01-21 - paediatric investigation plan

Izaflortaucipir (18F)
PIPHuman

Key facts

Active Substance
Izaflortaucipir (18F)
Therapeutic area
Neurology
Decision number
P/0432/2021
PIP number
EMEA-003040-PIP01-21
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Diagnosis of corticobasal degeneration
  • Treatment of progressive supranuclear palsy
Route(s) of administration
Intravenous use
Contact for public enquiries

Life Molecular Imaging GmbH

Email: gra@life-mi.com
Tel. +49 30461124603

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page